Pinnacle Financial Partners Inc Sells 96,704 Shares of HCA Healthcare, Inc. $HCA

Pinnacle Financial Partners Inc lessened its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 49.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 98,617 shares of the company’s stock after selling 96,704 shares during the period. HCA Healthcare accounts for 1.0% of Pinnacle Financial Partners Inc’s holdings, making the stock its 19th biggest holding. Pinnacle Financial Partners Inc’s holdings in HCA Healthcare were worth $42,031,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Brighton Jones LLC acquired a new position in shares of HCA Healthcare in the fourth quarter worth approximately $1,021,000. NewEdge Advisors LLC increased its position in shares of HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the period. MassMutual Private Wealth & Trust FSB lifted its holdings in HCA Healthcare by 32.1% in the second quarter. MassMutual Private Wealth & Trust FSB now owns 642 shares of the company’s stock valued at $246,000 after buying an additional 156 shares during the period. Balefire LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $238,000. Finally, Financiere des Professionnels Fonds d investissement inc. bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at about $208,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the sale, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Down 3.0%

HCA stock opened at $469.08 on Friday. The firm has a market capitalization of $107.04 billion, a PE ratio of 18.13, a P/E/G ratio of 1.33 and a beta of 1.36. The stock’s 50 day moving average is $480.49 and its 200-day moving average is $430.45. HCA Healthcare, Inc. has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating the consensus estimate of $5.64 by $1.32. The business had revenue of $19.16 billion for the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business’s revenue was up 9.6% on a year-over-year basis. During the same period last year, the business earned $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Monday, December 15th. HCA Healthcare’s dividend payout ratio (DPR) is 11.13%.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Leerink Partners raised its price target on HCA to $507 and kept an “outperform” rating, signaling analyst confidence in HCA’s earnings trajectory and providing a near-term valuation upside catalyst. Leerink Partners lifts price target on HCA Healthcare to $507
• Positive Sentiment: HCA plans to operate 81 freestanding emergency departments in Florida by the end of Q1, reflecting measurable expansion of outpatient / ED capacity that can drive admissions and higher-margin volumes. HCA to have 81 freestanding EDs in Florida by end of Q1
• Positive Sentiment: Regional partnership expansion in Tennessee positions HCA for market share and referral network growth in a fast-growing region. These deals support medium-term revenue expansion without full hospital acquisitions. Tennessee systems to deepen partnership as HCA eyes growth in region
• Neutral Sentiment: HCA promoted Erica Rossitto to chief nurse executive (effective Feb. 1), strengthening nursing leadership for HCA’s 100,000+ nurses — governance/operational news that supports execution but is not an immediate earnings driver. HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
• Neutral Sentiment: Local executive moves (interim chief nurse at an HCA Missouri hospital and other chief nursing appointments) are operational-level items with limited near-term market impact. HCA Missouri hospital names interim chief nurse
• Neutral Sentiment: Third-party health-tech and regional care updates (Medical City Plano CFO change, Memorial Health CT adoption) mentioned in the newsfeed are industry context but not direct HCA drivers. Healthcare Briefs: Medical City Plano’s New CFO and Cariloop’s Partnership With Raymond James
• Negative Sentiment: L1 Capital trimmed its HCA position, citing share-price appreciation; portfolio selling from a notable fund can create near-term supply pressure and contribute to today’s down move. L1 Capital Trimmed HCA Healthcare Due to Share Price Appreciation

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Sanford C. Bernstein restated a “market perform” rating and set a $503.00 price target on shares of HCA Healthcare in a report on Tuesday, January 6th. KeyCorp raised their price target on shares of HCA Healthcare from $465.00 to $475.00 and gave the stock an “overweight” rating in a report on Monday, October 27th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $431.00 to $452.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 7th. Wall Street Zen raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Finally, Jefferies Financial Group boosted their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a report on Tuesday, October 28th. Fifteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $487.00.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.